you are viewing a single comment's thread.
Also, Aeterna did not reveal the percentage of royalty it will get from the sale of Perifosine if it is approved and market sucessfully. That number could be very high.
It is confirmed to be in the low double digits.BK
Which means between 10% to 49%.
Lets say if the percentage is 30%, and the sale is $1 billion, then Aeterna will get $300 million. Which is a very large sum of revenue. Plus Aeterna save a huge amount of money that KERX will spend to manufacture, comercialize and market Perifone.
AEZS also will manufacture perifosine on a cost plus basis to all partners. They get royalty payments in the low double digits.BK